Sanofi (NASDAQ:SNY) Shares Acquired by Tang Capital Management LLC

Tang Capital Management LLC raised its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 285.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 270,000 shares of the company's stock after acquiring an additional 200,000 shares during the period. Tang Capital Management LLC's holdings in Sanofi were worth $13,022,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SNY. Price T Rowe Associates Inc. MD grew its holdings in shares of Sanofi by 88.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,843,682 shares of the company's stock valued at $522,991,000 after purchasing an additional 5,091,304 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Sanofi in the fourth quarter valued at approximately $135,933,000. Boston Partners grew its holdings in shares of Sanofi by 86.4% in the fourth quarter. Boston Partners now owns 5,396,531 shares of the company's stock valued at $260,607,000 after purchasing an additional 2,501,073 shares in the last quarter. Magnetar Financial LLC grew its holdings in shares of Sanofi by 104.3% in the fourth quarter. Magnetar Financial LLC now owns 3,340,317 shares of the company's stock valued at $161,103,000 after purchasing an additional 1,705,148 shares in the last quarter. Finally, Point72 Asset Management L.P. grew its holdings in shares of Sanofi by 969.6% in the fourth quarter. Point72 Asset Management L.P. now owns 950,649 shares of the company's stock valued at $45,850,000 after purchasing an additional 861,770 shares in the last quarter. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SNY has been the subject of a number of recent research reports. The Goldman Sachs Group initiated coverage on shares of Sanofi in a research note on Friday, March 21st. They issued a "neutral" rating and a $65.00 price target for the company. Hsbc Global Res upgraded shares of Sanofi to a "strong-buy" rating in a research note on Monday, April 28th. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a "sell" rating to a "hold" rating in a research note on Thursday, January 30th. Sanford C. Bernstein upgraded shares of Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. Finally, BNP Paribas began coverage on shares of Sanofi in a research note on Tuesday, April 15th. They issued an "outperform" rating and a $65.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, two have given a buy rating and three have given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $63.33.

Sanofi Stock Up 1.6%

Shares of NASDAQ:SNY opened at $51.68 on Friday. The company has a market capitalization of $130.56 billion, a PE ratio of 20.76, a P/E/G ratio of 1.01 and a beta of 0.55. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. Sanofi has a twelve month low of $45.80 and a twelve month high of $60.12. The firm has a 50 day simple moving average of $53.36 and a 200-day simple moving average of $51.89.

Sanofi (NASDAQ:SNY - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.04. The business had revenue of $10.41 billion during the quarter, compared to the consensus estimate of $9.79 billion. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The company's revenue was down 11.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.78 EPS. On average, equities analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Thursday, June 12th. Stockholders of record on Friday, May 9th will be given a dividend of $2.0369 per share. This represents a dividend yield of 3.1%. The ex-dividend date is Friday, May 9th. This is an increase from Sanofi's previous annual dividend of $1.48. Sanofi's payout ratio is currently 57.14%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.